#LCSM Chat Topic 5/18: What’s PFS Got to Do with It?

For our chat on 5/18/17, starting at 8 PM Eastern, 5 PM Pacific, we’ll cover several key trial results and the potential implications of them.  While each has the potential to be practice changing, all three have the primary endpoint of progression-free survival (PFS) but, to our knowledge, don’t necessarily improve overall survival (OS).  It is interesting that the differences between the settings and trial designs have led many lung cancer experts to favor adoption of some of these results but not necessarily others. But what do patients and caregivers think of… Read More

#LCSM Chat Topic 4/6: Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?

  Our topic for the next #LCSM Chat on Thursday, April 6th at 5 PM Pacific/ 8 PM Eastern is “Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD) In its most recent budget outline, the Trump administration is looking to propose an 18% cut to the National Institute of Health’s (NIH; @NIH) $31.7 billion budget (#trumpbudget).  In addition to this funding cut, the Trump administration proposes to 1) reorganize the current NIH institute structure and 2)… Read More

“What I Like About the IASLC World Conference on Lung Cancer” (#LCSM Chat on FB Live)

During a reception at the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria, #LCSM Chat co-moderator Janet Freeman-Daily asked other lung cancer patients and advocates what they liked most about the conference.  Their responses were captured via Facebook Live on the  Lung Cancer Social Media #LCSM Chat Facebook page December 4, 2016.   Thanks to the International Association for the Study of Lung Cancer (IASLC) for their cooperation in making this video.